Here is a list of top 10 stocks that are likely to be in focus on Monday:
TCSThe country’s largest software exporter TCS on Friday reported a 5.2 per cent rise in net profit for the June quarter. 9,478 crore, restricted by the impact of annual increments and promotions, which took operating profit margins to a multi-quarter low. The Tata group company, which is the first company to report earnings in the country’s USD 220 billion-plus software export industry, said it does not see any adverse business impact due to slowdown concerns in its key markets.
Avenue SupermartsAvenue Supermarts Ltd., which owns and operates hypermarket chain D-Mart, reported a standalone net profit on Saturday 680 crore for the first quarter of the current financial year as compared to 115 crore in the corresponding period of last year, registering a nearly six-fold jump.
WiproWipro Limited is overhauling its employees’ bonus and salary hikes to curb high attrition and attract new talent as India’s technology sector sees a Covid-induced surge in hiring. India’s fourth-largest software services firm plans to give employees promotions every quarter—a first for the Bengaluru-based company—and hike salaries of most of its employees by up to 10% in September, giving top performers 15% More increase was achieved.
Bandhan BankBandhan Bank advances up 20 percent over a year ago 96,649 crore till June 30, the bank said on Friday. Private sector lender’s total deposits also increased by 20 percent 93,057 crore by the end of Q1 FY23, Bandhan Bank said in a regulatory filing.
Monte Carlo FashionsApparel brand Monte Carlo Fashions on Friday reported more than two times revenue growth in the April-June quarter of the current fiscal, helped by sales growth and value addition. Monte Carlo Fashions said, “During the quarter, the company saw strong demand across all segments in revenue as things return to normal. It posted strong sales in Q1 with strong revenue growth of around 130 per cent in Q1 FY23 Has been.” Business update for Q1 FY2022-23.
Dr Reddy’s LabDr Reddy’s Laboratories Ltd on Friday said it has launched its generic version of fesoterodine fumarate extended-release tablet used to treat overactive bladder in the US market. The launch follows the approval given by the US Food and Drug Administration (USFDA), the pharma company said in a regulatory filing.
Aurobindo PharmaAurobindo Pharma is focused on developing complex and differentiated products across multiple sectors including oncology, hormonal products, biosimilars, depot injections and vaccines to drive the next phase of growth, according to its annual report for 2021-22.
HDFC: Regulator PFRDA has approved changes in the constitution of HDFC Ltd ahead of its merger with its banking subsidiary HDFC Bank, and directed that the services of NPS customers linked to the corporation should not be affected.
Zydus LifesciencesZydus Lifesciences Ltd on Friday said it has launched a generic version of sitagliptin in India under the brand names Sitaglin and Ciglin to combat type 2 diabetes. Sitaglin and Ciglin provide an oral solution to provide ease and better compliance to patients, the company said in a regulatory filing.
PGCILState-owned Power Grid Corporation of India Limited (PGCIL) has bagged an inter-state transmission project for power extraction from Neemuch SEZ in Madhya Pradesh. PGCIL has won the project through a tariff-based competitive bidding process.